← Insider buys
ARDX

Ardelyx, Inc. · Healthcare

SVP, Drug Development David P. Rosenbaum sold $56K of Ardelyx, Inc.

Sold$55,898
$22.01Price
2,540Shares
−2%Stake

What ARDX did after the filing

Prices for ARDX after this filing aren't in yet.

Traded Tue, Sep 15. Filed Mon, Mar 7. Not investment advice.